Nebulized Ketamine for the Treatment of Major Depressive Disorder in an Inpatient Setting: A Midazolam-controlled Randomized Controlled Trial

Phase: PHASE3 | Sponsor: Theresa Jacob, PhD, MPH | Compound: Ketamine

Status

recruiting

Institution

Theresa Jacob, PhD, MPH

Start date

2024-10-16

End date

2026-09-30

Registry ID

NCT06752759

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.